Nanox Imaging is reporting slight revenue increases for the third quarter of the 2024 fiscal year, which ended September 30.
The company generated $3 million in revenue in the quarter, compared to $2.5 million in the third quarter of 2023. It also reported a net loss of $13.6 million for the quarter, compared to a net loss of $21.4 million for the same period in 2023.
The company's highlights in the third quarter included the signing of new distribution agreements with SpinexMedical and the extension of agreements with Nanox.AI users such as Corewell Health, Dandelion Health, and Oxford University Hospitals.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
